Constitutive aryl hydrocarbon receptor signaling constrains type I interferon–mediated antiviral innate defense-Reference-Cited by-同舟云学术

Constitutive aryl hydrocarbon receptor signaling constrains type I interferon–mediated antiviral innate defense

Published:2016-04-18 Issue:6 Volume:17 Page:687-694
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Yamada Taisho,Horimoto Hiromasa,Kameyama Takeshi,Hayakawa Sumio,Yamato Hiroaki,Dazai Masayoshi,Takada Ayato,Kida Hiroshi,Bott Debbie,Zhou Angela C,Hutin David,Watts Tania H^ORCID,Asaka Masahiro,Matthews Jason,Takaoka Akinori

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3422.pdf

Reference57 articles.

1. Lindén, J., Lensu, S., Tuomisto, J. & Pohjanvirta, R. Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Front. Neuroendocrinol. 31, 452–478 (2010).

2. Denison, M.S. & Nagy, S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309–334 (2003).

3. Hu, W., Sorrentino, C., Denison, M.S., Kolaja, K. & Fielden, M.R. Induction of Cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol. Pharmacol. 71, 1475–1486 (2007).

4. Murray, I.A., Patterson, A.D. & Perdew, G.H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer 14, 801–814 (2014).

5. Diani-Moore, S. et al. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 285, 38801–38810 (2010).

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroquinone impairs trophoblast migration and invasion via AHR-twist-IFITM1 axis;Placenta;2024-09

2. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective;eBioMedicine;2024-09

3. Timing influences the impact of aryl hydrocarbon receptor activation on the humoral immune response to respiratory viral infection;Toxicology and Applied Pharmacology;2024-08

4. Targeting chromosomal instability in patients with cancer;Nature Reviews Clinical Oncology;2024-07-11

5. Discovery of highly potent PARP7 inhibitors for cancer immunotherapy;Bioorganic Chemistry;2024-07